Literature DB >> 18191892

Validation of the CALUX bioassay as a screening and semi-quantitative method for PCDD/F levels in cow's milk.

I-Cheng Chou1, Wen-Jhy Lee, Lin-Chi Wang, Guo-Ping Chang-Chien, Wei-Shan Lee, Hsinyu Lee.   

Abstract

The objectives of this study were first to set up and validate the quality criteria of the Xenobiotic Detection Systems-chemical activated luciferase gene expression (CALUX) bioassay for the analysis of cow's milk samples spiked with polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans (PCDD/Fs). The application of this bioassay was then tested by analyzing 28 commercially available pasteurized milk samples and comparing the data with the reference method for PCDD/F analysis. The CALUX criteria from the U.S. EPA and the European Union (EU) were calculated from 16 replaced spiked milk (SM) samples and 8 performance evaluation (PE) samples to validate the CALUX bioassay system. The CALUX bioassay criteria included control chart for quality control (QC) standards, recovery efficiency, and data comparability. The control chart for QC standards were both within the micro+/-2sigma range. The recovery efficiencies ranged from 60.4% to 106% with an average of 79.9% (relative standard deviation (RSD): 20.7%). The mean of data comparability (i.e., relative percent difference, RPD) between CALUX bioassay and high-resolution gas chromatography and high-resolution mass spectrometry (HRGC/HRMS) was 19.0% for SM samples. For the PE samples, Pearson's correlation coefficient between CALUX and the HRGC/HRMS method was 0.953. The high correlation shows that the CALUX system is suitable as a screening method and a semi-quantitative method to analyze the PCDD/F concentration in milk samples. Next, the validated CALUX bioassay was applied to measure 28 commercially available pasteurized milk samples. These milk samples were also analyzed with the HRGC/HRMS method to compare the analysis data from two different methods. There is no false negative sample when applying the bioassay to pasteurized milk and PE samples as a screening method and a semi-quantitative method. The present study indicates that CALUX is a powerful bioassay method for screening a large number of milk samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191892     DOI: 10.1016/j.jhazmat.2007.11.023

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  4 in total

1.  Associations between endocrine disrupting chemicals and equine metabolic syndrome phenotypes.

Authors:  S A Durward-Akhurst; N E Schultz; E M Norton; A K Rendahl; H Besselink; P A Behnisch; A Brouwer; R J Geor; J R Mickelson; M E McCue
Journal:  Chemosphere       Date:  2018-11-26       Impact factor: 7.086

2.  Quantification of PCDD/Fs and dioxin-like PCBs in small amounts of human serum using the sensitive H1L7.5c1 mouse hepatoma cell line: optimization and analysis of human serum samples from adolescents of the Flemish human biomonitoring program FLEHS II.

Authors:  K Croes; K Van Langenhove; E Den Hond; L Bruckers; A Colles; G Koppen; I Loots; V Nelen; G Schoeters; T Nawrot; N Van Larebeke; M S Denison; T Vandermarken; M Elskens; W Baeyens
Journal:  Talanta       Date:  2011-08-05       Impact factor: 6.057

3.  Determination of PCDD/Fs, PBDD/Fs and dioxin-like PCBs in human milk from mothers residing in the rural areas in Flanders, using the CALUX bioassay and GC-HRMS.

Authors:  K Croes; A Colles; G Koppen; S De Galan; T Vandermarken; E Govarts; L Bruckers; V Nelen; G Schoeters; N Van Larebeke; M S Denison; M Mampaey; W Baeyens
Journal:  Talanta       Date:  2013-04-06       Impact factor: 6.057

4.  Revised relative potency values for PCDDs, PCDFs, and non-ortho-substituted PCBs for the optimized H4IIE-luc in vitro bioassay.

Authors:  Kyu Tae Lee; Seongjin Hong; Jung Suk Lee; Kyu Hyuck Chung; Klara Hilscherová; John P Giesy; Jong Seong Khim
Journal:  Environ Sci Pollut Res Int       Date:  2013-05-21       Impact factor: 4.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.